Literature DB >> 26109807

Long noncoding RNAs in hepatitis B virus-related hepatocellular carcinoma.

Ting-Ting Yu1, Xi-Ming Xu1, Yi Hu1, Jun-Jian Deng1, Wei Ge1, Na-Na Han1, Mei-Xia Zhang1.   

Abstract

AIM: To study the expression of long noncoding RNAs (lncRNAs) in hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).
METHODS: The lncRNA profiles between HBV-related HCC tissues and corresponding normal liver tissues were generated using microarray analysis. Datasets were analyzed using multiple algorithms to depict alterations in gene expression on the basis of gene ontology (GO), pathway analysis, and lncRNA levels.
RESULTS: The microarray revealed that 1772 lncRNAs and 2508 mRNAs were differently expressed. The pathway analysis demonstrated that the cell cycle, cytokine-cytokine receptor interaction, chemokine signaling pathway, and phosphoinositide 3-kinase-protein kinase B signaling pathway may play important roles in HCC. Several GO terms, such as cell cycle, DNA replication, immune response, and signal transduction, were enriched in gene lists, suggesting a potential correlation with HBV-related HCC. The upregulated large intergenic noncoding RNA ULK4P2 was physically combined with enhancer of zeste homolog 2. Therefore, the lncRNAs may participate in regulating HBV-related HCC.
CONCLUSION: lncRNAs play important roles in HCC, future studies should verify whether large intergenic noncoding ULK4P2 functions by combining with enhancer of zeste homolog 2 in HCC.

Entities:  

Keywords:  Enhancer of zeste homolog 2; Hepatocellular carcinoma; Long noncoding RNAs; Microarray; ULK4P2

Mesh:

Substances:

Year:  2015        PMID: 26109807      PMCID: PMC4476882          DOI: 10.3748/wjg.v21.i23.7208

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

Review 1.  Genome regulation by long noncoding RNAs.

Authors:  John L Rinn; Howard Y Chang
Journal:  Annu Rev Biochem       Date:  2012       Impact factor: 23.643

2.  Polycomb EZH2 controls self-renewal and safeguards the transcriptional identity of skeletal muscle stem cells.

Authors:  Aster H Juan; Assia Derfoul; Xuesong Feng; James G Ryall; Stefania Dell'Orso; Alessandra Pasut; Hossein Zare; James M Simone; Michael A Rudnicki; Vittorio Sartorelli
Journal:  Genes Dev       Date:  2011-04-15       Impact factor: 11.361

3.  Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans.

Authors:  Fu Yang; Ling Zhang; Xi-song Huo; Ji-hang Yuan; Dan Xu; Sheng-xian Yuan; Nan Zhu; Wei-ping Zhou; Guang-shun Yang; Yu-zhao Wang; Jing-li Shang; Chun-fang Gao; Feng-rui Zhang; Fang Wang; Shu-han Sun
Journal:  Hepatology       Date:  2011-09-06       Impact factor: 17.425

4.  Long noncoding RNAs with enhancer-like function in human cells.

Authors:  Ulf Andersson Ørom; Thomas Derrien; Malte Beringer; Kiranmai Gumireddy; Alessandro Gardini; Giovanni Bussotti; Fan Lai; Matthias Zytnicki; Cedric Notredame; Qihong Huang; Roderic Guigo; Ramin Shiekhattar
Journal:  Cell       Date:  2010-10-01       Impact factor: 41.582

5.  MEG3 imprinted gene contribution in tumorigenesis.

Authors:  Leonidas Benetatos; George Vartholomatos; Eleftheria Hatzimichael
Journal:  Int J Cancer       Date:  2011-05-05       Impact factor: 7.396

6.  Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation.

Authors:  Zhe Yang; Lin Zhou; Li-Ming Wu; Ming-Chun Lai; Hai-Yang Xie; Feng Zhang; Shu-Sen Zheng
Journal:  Ann Surg Oncol       Date:  2011-02-15       Impact factor: 5.344

7.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

Review 8.  The emergence of lncRNAs in cancer biology.

Authors:  John R Prensner; Arul M Chinnaiyan
Journal:  Cancer Discov       Date:  2011-10       Impact factor: 39.397

Review 9.  Non-coding RNAs as regulators of mammary development and breast cancer.

Authors:  Hai-Long Piao; Li Ma
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-02-17       Impact factor: 2.673

10.  lincRNAs act in the circuitry controlling pluripotency and differentiation.

Authors:  Mitchell Guttman; Julie Donaghey; Bryce W Carey; Manuel Garber; Jennifer K Grenier; Glen Munson; Geneva Young; Anne Bergstrom Lucas; Robert Ach; Laurakay Bruhn; Xiaoping Yang; Ido Amit; Alexander Meissner; Aviv Regev; John L Rinn; David E Root; Eric S Lander
Journal:  Nature       Date:  2011-08-28       Impact factor: 49.962

View more
  9 in total

1.  SSTR5‑AS1 functions as a ceRNA to regulate CA2 by sponging miR‑15b‑5p for the development and prognosis of HBV‑related hepatocellular carcinoma.

Authors:  Jing Xu; Jing Zhang; Fenglian Shan; Jie Wen; Yue Wang
Journal:  Mol Med Rep       Date:  2019-10-11       Impact factor: 2.952

Review 2.  Diversity of Dysregulated Long Non-Coding RNAs in HBV-Related Hepatocellular Carcinoma.

Authors:  Nazia Samudh; Creanne Shrilall; Patrick Arbuthnot; Kristie Bloom; Abdullah Ely
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 7.561

Review 3.  Long noncoding RNAs in hepatitis B virus replication and oncogenesis.

Authors:  Hui-Chun Li; Chee-Hing Yang; Shih-Yen Lo
Journal:  World J Gastroenterol       Date:  2022-07-07       Impact factor: 5.374

4.  Comprehensive analysis of long non-coding RNA expression profiles in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Xianli Gong; Wei Wei; Lan Chen; Zhi Xia; Chengbo Yu
Journal:  Oncotarget       Date:  2016-07-05

5.  Alcohol and hepatitis virus-dysregulated lncRNAs as potential biomarkers for hepatocellular carcinoma.

Authors:  Hao Zheng; Pinxue Li; James G Kwok; Avinaash Korrapati; Wei Tse Li; Yuanhao Qu; Xiao Qi Wang; Tatiana Kisseleva; Jessica Wang-Rodriguez; Weg M Ongkeko
Journal:  Oncotarget       Date:  2017-12-05

6.  Transcriptomic profiling of long non-coding RNAs in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Hongxia Fan; Qiaoge Zhang; Xiaopei Zhao; Ping Lv; Min Liu; Hua Tang
Journal:  Oncotarget       Date:  2017-06-30

Review 7.  Oncolytic viruses against cancer stem cells: A promising approach for gastrointestinal cancer.

Authors:  Fang Huang; Bin-Rong Wang; Ye-Qing Wu; Fan-Chao Wang; Jian Zhang; Yi-Gang Wang
Journal:  World J Gastroenterol       Date:  2016-09-21       Impact factor: 5.742

8.  Development Of A Three-Gene Prognostic Signature For Hepatitis B Virus Associated Hepatocellular Carcinoma Based On Integrated Transcriptomic Analysis.

Authors:  Yao Yang; Qian Lu; Xuejun Shao; Banghui Mo; Xuqiang Nie; Wei Liu; Xianhua Chen; Yuan Tang; Youcai Deng; Jun Yan
Journal:  J Cancer       Date:  2018-04-30       Impact factor: 4.207

9.  The long noncoding RNA TUG1 acts as a competing endogenous RNA to regulate the Hedgehog pathway by targeting miR-132 in hepatocellular carcinoma.

Authors:  Jingjing Li; Qinghui Zhang; Xiaoming Fan; Wenhui Mo; Weiqi Dai; Jiao Feng; Liwei Wu; Tong Liu; Sainan Li; Shizan Xu; Wenwen Wang; Xiya Lu; Qiang Yu; Kan Chen; Yujing Xia; Jie Lu; Yingqun Zhou; Ling Xu; Chuanyong Guo
Journal:  Oncotarget       Date:  2017-07-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.